Hot
MGI announces partnership with Nalagenetics to advance pharmacogenomics in Singapore and Indonesia
SINGAPORE, 19 April 2022 DNBSEQ-G400 The collaboration aims to use NALA's Clinical Decision Support, a software medical device, to be able to analyze whole genome sequencing data sets generated by MGI's DNBSEQTM sequencing platform* and generate clinical-grade reports for pharmacogenomics and polygenic risk scores. Although NGS has been known to be an effective way to capture a large amount of genomic information to guide and tailor clinical management and treatment, "Pharmacogenetic testing ...
More2022-04-20